Pfizer Limited (NSE:PFIZER)
5,147.00
+111.00 (2.20%)
Oct 1, 2025, 3:30 PM IST
Pfizer Market Cap
Pfizer has a market cap or net worth of 235.65 billion as of October 2, 2025. Its market cap has decreased by -15.47% in one year.
Market Cap
235.65B
Enterprise Value
208.90B
Revenue
23.22B
Ranking
n/a
PE Ratio
29.14
Stock Price
5,147.00
Market Cap Chart
Since March 12, 1999, Pfizer's market cap has increased from 33.02B to 235.65B, an increase of 613.74%. That is a compound annual growth rate of 7.68%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 1, 2025 | 235.65B | -2.47% |
Dec 31, 2024 | 241.62B | 23.72% |
Dec 29, 2023 | 195.29B | -3.67% |
Dec 30, 2022 | 202.74B | -12.34% |
Dec 31, 2021 | 231.27B | -1.01% |
Dec 31, 2020 | 233.62B | 20.88% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 3,925.79B |
Divi's Laboratories | 1,515.83B |
Cipla | 1,222.15B |
Apollo Hospitals Enterprise | 1,065.30B |
Mankind Pharma | 1,005.36B |
Zydus Lifesciences | 997.33B |
Fortis Healthcare | 747.14B |
Alkem Laboratories | 652.77B |